Literature DB >> 606442

The activation of the C3b feedback cycle with human complement components. I. Through the classical pathway.

L W Mak, P J Lachmann, J Majewski.   

Abstract

Reaction between the fourth, the oxidized second and the activated first components of human complement generated the stable enzyme C4oxy2 capable of cleaving the third component and depleting total complement in human serum. This enzyme was shown further to activate the C3b feedback cycle as shown by its ability to consume factor B in serum and the reduction in the extent of complement consumption in the presence of EDTA. OxyC2 on its own gave rise to C3 cleavage in normal human serum by a pathway needing classical pathway components. This unexpected finding suggests that there may be a 'C-1 tickover' in serum analogous to the 'C3b tickover'; the presence of oxyC2 allowing the 'capture' of the trivial amounts of C42 normally formed. In preliminary experiments in the rat, C4oxy2 was successfully formed in vivo, where it gave rise to cleavage of C3, consumption of C5, depletion of cobra venom factor cofactors and a biphasic change in the neutrophil count.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 606442      PMCID: PMC1541131     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  [Acute lupus erythematosus with total absence of the C4 fraction of complement].

Authors:  G Hauptmann; E Grosshans; E Heid; S Mayer; A Basset
Journal:  Nouv Presse Med       Date:  1974-04-06

2.  Electrophoretic studies of the conversion products of serum beta-1C-globulin.

Authors:  C B Laurell; B Lundh
Journal:  Immunology       Date:  1967-03       Impact factor: 7.397

3.  Reaction mechanism of the alternative pathway of complement fixation.

Authors:  P J Lachmann; P Nicol
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

4.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

5.  New biological activity following intravascular activation of the complement cascade.

Authors:  C E McCall; L R De Chatelet; D Brown; P Lachmann
Journal:  Nature       Date:  1974-06-28       Impact factor: 49.962

6.  The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.

Authors:  V Brade; G D Lee; A Nicholson; H S Shin; M M Mayer
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

7.  Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement.

Authors:  W Vogt; L Dieminger; R Lynen; G Schmidt
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-02

8.  Prolonged C3 depletion by cobra venom factor in thymus-deprived mice and its implication for the role of C3 as an essential second signal for B-cell triggering.

Authors:  J Pryjma; J H Humphrey
Journal:  Immunology       Date:  1975-03       Impact factor: 7.397

9.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  5 in total

1.  Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme.

Authors:  L Halbwachs; M Leveillé; P Lesavre; S Wattel; J Leibowitch
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

2.  The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.

Authors:  C A Fijen; R G Bredius; E J Kuijper; T A Out; M De Haas; A P De Wit; M R Daha; J G De Winkel
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  Hypercomplementemia in adult patients with IgA nephropathy.

Authors:  Kisara Onda; Hiroyuki Ohi; Mariko Tamano; Isao Ohsawa; Michiro Wakabayashi; Satoshi Horikoshi; Teizo Fujita; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

4.  The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathway.

Authors:  L W Mak; J Majewski; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

5.  Continual low-level activation of the classical complement pathway.

Authors:  A P Manderson; M C Pickering; M Botto; M J Walport; C R Parish
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.